{"pmid":32333969,"title":"Response to COVID -19 and Diabetes: Can DPP4 Inhibition Play a Role? - GLP-1 Might Play One Too.","text":["Response to COVID -19 and Diabetes: Can DPP4 Inhibition Play a Role? - GLP-1 Might Play One Too.","Diabetes Res Clin Pract","Morin, Nathaniel","32333969"],"journal":"Diabetes Res Clin Pract","authors":["Morin, Nathaniel"],"date":"2020-04-26T11:00:00Z","year":2020,"_id":"32333969","week":"202017|Apr 20 - Apr 26","doi":"10.1016/j.diabres.2020.108160","keywords":["covid","glucagon like peptide 1 (glp-1)","hyperglycemia","interleukin 6 (il-6)"],"source":"PubMed","topics":["Treatment","Mechanism"],"weight":1,"_version_":1665071049731997696,"score":8.518259,"similar":[{"pmid":32224164,"title":"COVID-19 and diabetes: Can DPP4 inhibition play a role?","text":["COVID-19 and diabetes: Can DPP4 inhibition play a role?","Diabetes Res Clin Pract","Iacobellis, Gianluca","32224164"],"journal":"Diabetes Res Clin Pract","authors":["Iacobellis, Gianluca"],"date":"2020-04-01T11:00:00Z","year":2020,"_id":"32224164","week":"202014|Mar 30 - Apr 05","doi":"10.1016/j.diabres.2020.108125","source":"PubMed","topics":["Mechanism","Treatment"],"weight":1,"_version_":1664640912798515201,"score":247.77412},{"pmid":32333972,"title":"Letter to the Editor in response to the article \"COVID-19 and diabetes: Can DPP4 inhibition play a role?\"","text":["Letter to the Editor in response to the article \"COVID-19 and diabetes: Can DPP4 inhibition play a role?\"","Diabetes Res Clin Pract","Kokic Males, Visnja","32333972"],"journal":"Diabetes Res Clin Pract","authors":["Kokic Males, Visnja"],"date":"2020-04-26T11:00:00Z","year":2020,"_id":"32333972","week":"202017|Apr 20 - Apr 26","doi":"10.1016/j.diabres.2020.108163","source":"PubMed","topics":["Treatment","Mechanism"],"weight":1,"_version_":1665071049744580609,"score":228.3313},{"pmid":32286607,"title":"Might renin-angiotensin system blockers play a role in the COVID-19 pandemic?","text":["Might renin-angiotensin system blockers play a role in the COVID-19 pandemic?","Since December 2019, a new coronavirus, named SARS-CoV-2, has spread globally, affecting >200 000 people worldwide with the so-called COVID-19 disease. The scientific community is actively and constantly working to identify the mechanisms involved in the diffusion of this virus and the pathogenesis of the infection, with its most frequent and severe complication, namely interstitial pneumonia. To date, SARS-CoV-2 is known to enter the host cells via the angiotensin-converting enzyme 2 protein. For this reason, the hypothesis that drugs capable of increasing the expression of this protein may have a role in the spread of the virus and in the symptomatology of affected patients has taken hold. The purpose of this Editorial is to briefly show the evidence currently available in this regard and to provide ideas for future research.","Eur Heart J Cardiovasc Pharmacother","Battistoni, Allegra","Volpe, Massimo","32286607"],"abstract":["Since December 2019, a new coronavirus, named SARS-CoV-2, has spread globally, affecting >200 000 people worldwide with the so-called COVID-19 disease. The scientific community is actively and constantly working to identify the mechanisms involved in the diffusion of this virus and the pathogenesis of the infection, with its most frequent and severe complication, namely interstitial pneumonia. To date, SARS-CoV-2 is known to enter the host cells via the angiotensin-converting enzyme 2 protein. For this reason, the hypothesis that drugs capable of increasing the expression of this protein may have a role in the spread of the virus and in the symptomatology of affected patients has taken hold. The purpose of this Editorial is to briefly show the evidence currently available in this regard and to provide ideas for future research."],"journal":"Eur Heart J Cardiovasc Pharmacother","authors":["Battistoni, Allegra","Volpe, Massimo"],"date":"2020-04-15T11:00:00Z","year":2020,"_id":"32286607","week":"202016|Apr 13 - Apr 19","doi":"10.1093/ehjcvp/pvaa030","keywords":["hypertension","ras system","sars-cov-2"],"source":"PubMed","topics":["Treatment","Mechanism"],"weight":1,"_version_":1664636391597801473,"score":124.2038},{"pmid":32240958,"title":"The COVID-19 outbreak: Crucial role the psychiatrists can play.","text":["The COVID-19 outbreak: Crucial role the psychiatrists can play.","Asian J Psychiatr","Banerjee, Debanjan","32240958"],"journal":"Asian J Psychiatr","authors":["Banerjee, Debanjan"],"date":"2020-04-03T11:00:00Z","year":2020,"_id":"32240958","week":"202014|Mar 30 - Apr 05","doi":"10.1016/j.ajp.2020.102014","source":"PubMed","weight":0,"_version_":1664638354139906049,"score":117.6619},{"pmid":32250170,"title":"Will plant-made biopharmaceuticals play a role in the fight against COVID-19?","text":["Will plant-made biopharmaceuticals play a role in the fight against COVID-19?","Expert Opin Biol Ther","Rosales-Mendoza, Sergio","32250170"],"journal":"Expert Opin Biol Ther","authors":["Rosales-Mendoza, Sergio"],"date":"2020-04-07T11:00:00Z","year":2020,"_id":"32250170","week":"202015|Apr 06 - Apr 12","doi":"10.1080/14712598.2020.1752177","keywords":["COVID-19 vaccine","SARS-CoV-2 virus","biomanufacturing","mucosal immunization","plantibody"],"source":"PubMed","topics":["Treatment"],"weight":1,"_version_":1663352136275066880,"score":115.81857}]}